Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

This drug researcher just reported earnings and could keep rallying on biotech bounceback, JPMorgan says

A resurgence in investments in the biotechnology industry could further boost shares of Charles River Laboratories, according to JPMorgan.

We haven't written up this one. CNBC has the full story — the link below goes straight to it.

Read the original at cnbc.com →

More in Finance & Markets

More from Thursday 6 August →